AzTrials
AzTrials

Periodontal DiseasesPhase 2/3NCT02560870

Compare the Efficacy of Aloe Vera Mouthwash With Non- Alcoholic Chlorhexidine Mouthwash on Periodontal Diseases

A Phase 2/3 study testing Active Comparator:Aloe Vera mouthwash and Active Comparator:Chlorhexidine mouthwash in people with Periodontal Diseases, run by Islamic Azad University, Sanandaj.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim: To compare the efficacy of Aloe Vera and non-alcoholic chlorhexidine mouthwash in the treatment of Periodontal diseases. Methods \&Material: 32 patients were selected, the following periodontal parameters were recorded at baseline, and after recording all the parameters at the baseline, Scaling, root planning… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Periodontal Diseases
What is being tested?
Active Comparator:Aloe Vera mouthwash and Active Comparator:Chlorhexidine mouthwash
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
No sites listed yet
Study dates
Mar 2014to May 2015
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Presence of two periodontal sites located on the same side pocket depth 4 mm or more.
  • Chronic periodontitis patients.

Who cannot join

  • Orthodontic treatment.
  • Use removal denture.
  • Presence of vertical bone defect.
  • Use of medicine therapy within the 3 months prior to the study.
  • Allergy to chlorhexidine and Aloe Vera.
  • smoking.
Show all 12Show fewer
  • Systemic diseases that could influence the course of periodontal disease.
  • Pregnancy and lactation.
  • Aggressive periodontitis.
  • Furcation involvement.
  • Periodontal therapy 6 months prior to the study.
  • Extensive caries.

About this study

Official title: Randomized, Clinical Trial to Evaluate the Effects of Aloe Vera Mouthwash in Comparison With Non-alcoholic Chlorhexidine on Periodontal Disease

Aim: To compare the efficacy of Aloe Vera and non-alcoholic chlorhexidine mouthwash in the treatment of Periodontal diseases.

Methods \&Material: 32 patients were selected, the following periodontal parameters were recorded at baseline, and after recording all the parameters at the baseline, Scaling, root planning, and polishing are done for all the patients participating in the study. Oral hygiene instructions were given that included brushing twice a day with a soft brush, After 2 weeks, patients in the study, were randomly (Balanced Block Randomization) equal divided into 2 groups;

Group A: mouthwash aloe Vera (Alodent Co. UK) for each patient, Group B: Non-alcoholic Chlorhexidine (Perio-Kin, Livar CO. Spain) 10 ml by patients routinely washed two times in one day for about 30 seconds and lasts for 15 days, then every 7 days periodontal parameters, and at the end of 2 weeks (days 0, 7, 15) clinical changes are evaluated.

Read the detailed description

Eligible participants were 32 adult patients treated for chronic periodontitis and participating in a supportive periodontal therapy program at the Department of Periodontology of the Dental Clinic of the Islamic Azad University, Dental Branch of Tehran were included in the current study; Recruitment of participants started july 2014 and ended may 2015. The study met the criteria of the Helsinki Declaration of 1975, revised in 2008. The survey plan was reviewed and sanctioned, approved by the ethics commission of the Institutional Ethical Committee and Review Board of the Deputy of Research, School of Dentistry. All subjects received the oral and written explanation of the intent of the survey and signed an informed consent after receiving detailed information about the purpose, the benefits, and the possible risks associated with the trial. Individuals satisfying the following entry criteria were recruited:

  • Diagnosed suffering from initial (early) to moderate chronic periodontitis;
  • Adult patients, more than 28 years old with at least 20 remaining teeth and at least three teeth in each quadrant;
  • The presence of at least two residual sites with a probing pocket depth (PPD>4 mm in two opposite quadrants, which showed bleeding upon probing, radiographically comparable amount of periodontal breakdown and good matching in tooth type, also clinical and minimal radiographic signs of initial (early) to moderate (clinical attachment level of 1 to 3mm.
Being tested
Active Comparator:Aloe Vera mouthwash, Active Comparator:Chlorhexidine mouthwash
Medical subject headings
Periodontal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active Comparator:Aloe Vera mouthwashDrug

    Also called Aloe Vera mouthwash made by Alodent Co. UK

    mouthwash( Aloe Vera),10 ml by patients routinely washed two times in one day for about 30 seconds for two weeks.

  • Active Comparator:Chlorhexidine mouthwashDrug

    Also called Chlorhexidine mouthwash made by Perio-Kin, Livar CO. Spain

    mouthwash( Chlorhexidine ),10 ml by patients routinely washed two times in one day for about 30 seconds for two weeks.

Study groups in NCT02560870
Study groupRoleWhat they receive
Aloe Vera mouthwashActive comparatormouthwash (Aleo Vera)10 ml by patients routinely washed two times in one day for about 30 seconds for two weeks.
Receives: Drug: Active Comparator:Aloe Vera mouthwash
Chlorhexidine mouthwashActive comparatormouthwash (Chlorhexidine )10 ml by patients routinely washed two times in one day for about 30 seconds for two weeks.
Receives: Drug: Active Comparator:Chlorhexidine mouthwash

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reduction of pocket depth

    Periodontal pobe

    Measured: 7days

Secondary outcomes (2)
  1. Reduction of bleeding on probing

    Periodontal pobe

    Measured: 7days

  2. Reduction of plaque index

    Plaque Index(O'Leary )

    Measured: 7days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2015 (estimated)
  2. Study startMar 2014
  3. Primary completionApr 2015
  4. Study completionMay 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02560870
Sponsor's protocol ID
487
Status last verified
Jun 2016
First submitted
24 Sep 2015
Last updated
6 Jun 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Active Comparator:Aloe Vera mouthwash and Active Comparator:Chlorhexidine mouthwash in people with Periodontal Diseases, run by Islamic Azad University, Sanandaj.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reduction of pocket depth (time frame: 7days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in